In the past week, ALHC stock has gone down by -17.93%, with a monthly decline of -1.84% and a quarterly surge of 30.61%. The volatility ratio for the week is 5.71%, and the volatility levels for the last 30 days are 6.05% for Alignment Healthcare Inc The simple moving average for the last 20 days is -8.56% for ALHC stock, with a simple moving average of 36.73% for the last 200 days.
Is It Worth Investing in Alignment Healthcare Inc (NASDAQ: ALHC) Right Now?
Moreover, the 36-month beta value for ALHC is 1.45. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 6 as “overweight,” 3 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ALHC is 87.39M and currently, short sellers hold a 5.16% of that float. On November 15, 2024, ALHC’s average trading volume was 1.31M shares.
ALHC) stock’s latest price update
Alignment Healthcare Inc (NASDAQ: ALHC) has seen a decline in its stock price by -12.55 in relation to its previous close of 12.83. However, the company has experienced a -17.93% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-11-15 that Proceeds to be used to lower the Company’s cost of capital by repaying the Company’s existing term loan facility and for general corporate purposes Proceeds to be used to lower the Company’s cost of capital by repaying the Company’s existing term loan facility and for general corporate purposes
Analysts’ Opinion of ALHC
BofA Securities, on the other hand, stated in their research note that they expect to see ALHC reach a price target of $11, previously predicting the price at $7.75. The rating they have provided for ALHC stocks is “Buy” according to the report published on May 30th, 2024.
Robert W. Baird gave a rating of “Outperform” to ALHC, setting the target price at $10 in the report published on May 30th of the current year.
ALHC Trading at -3.14% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.27% of loss for the given period.
Volatility was left at 6.05%, however, over the last 30 days, the volatility rate increased by 5.71%, as shares surge +1.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.79% upper at present.
During the last 5 trading sessions, ALHC fell by -18.84%, which changed the moving average for the period of 200-days by +71.22% in comparison to the 20-day moving average, which settled at $12.26. In addition, Alignment Healthcare Inc saw 30.30% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from KONOWIECKI JOSEPH S, who sale 6,920 shares at the price of $13.73 back on Nov 11 ’24. After this action, KONOWIECKI JOSEPH S now owns 1,134,888 shares of Alignment Healthcare Inc, valued at $95,012 using the latest closing price.
Freeman Robert Thomas, the Chief Financial Officer of Alignment Healthcare Inc, sale 30,500 shares at $13.42 during a trade that took place back on Nov 11 ’24, which means that Freeman Robert Thomas is holding 92,929 shares at $409,356 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.1 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.06. The total capital return value is set at -0.36. Equity return is now at value -95.13, with -19.71 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.65 points at debt to capital in total, while cash flow to debt ratio is standing at -0.68. The debt to equity ratio resting at 1.85. The interest coverage ratio of the stock is -5.14.
Currently, EBITDA for the company is -105.3 million with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 0.83. The receivables turnover for the company is 17.77for trailing twelve months and the total asset turnover is 3.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
To wrap up, the performance of Alignment Healthcare Inc (ALHC) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
